Change in framingham risk score in patients with schizophrenia: a post hoc analysis of a randomized, double-blind, 6-week trial of ziprasidone and olanzapine (Q35574462)

From Wikidata
Jump to navigation Jump to search
scientific article published on January 2006
edit
Language Label Description Also known as
English
Change in framingham risk score in patients with schizophrenia: a post hoc analysis of a randomized, double-blind, 6-week trial of ziprasidone and olanzapine
scientific article published on January 2006

    Statements

    Change in framingham risk score in patients with schizophrenia: a post hoc analysis of a randomized, double-blind, 6-week trial of ziprasidone and olanzapine (English)
    Megan C Del Valle
    Antony D Loebel
    Stephen Murray
    Ruoyong Yang
    David J Harrison
    Brian J Cuffel
    1 January 2006

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit